Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Irvine, CA
SEC filing record 1 source field available
Fiscal year end
31 December
AEON Biopharma, Inc. has filed 334 SEC EDGAR filings since 23 Dec 2020

SEC filing history

Showing 1-8 of 8 matching filings.

Per page
25
Current page
1
SC 13G File 005-92271

SC 13G

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92271

AEON

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92271

AMENDMENT NO. 1

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92271

SC 13G filing

Filing date
31 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92271

FORM SC 13G/A

Filing date
20 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92271

SC 13G/A filing

Filing date
12 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92271

SC 13G filing

Filing date
10 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92271

PRIVETERRA ACQUISITION CORP.

Filing date
22 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .